Lectin Complement Pathway Gene Profile of Donor and Recipient Determine the Risk of Bacterial Infections After Orthotopic Liver Transplantation†,‡
Authors:
- Rogier W. Ten HoveRHRogier W. Ten Hove
- Minneke J. CoenraadMCMinneke J. Coenraad
- Andrzej G. BaranskiABAndrzej G. Baranski
Open Access
- 26 August 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 52 (3) , 1100-1110
Abstract
Infectious complications after orthotopic liver transplantation (OLT) are a major clinical problem. The lectin pathway of complement activation is liver-derived and a crucial effector of the innate immune defense against pathogens. Polymorphisms in lectin pathway genes determine their functional activity. We assessed the relationship between these polymorphic genes and clinically significant bacterial infections, i.e., sepsis, pneumonia, and intra-abdominal infection, and mortality within the first year after OLT, in relation to major risk factors in two cohorts from different transplant centers. Single-nucleotide polymorphisms in the mannose-binding lectin gene ( MBL2 ), the ficolin-2 gene ( FCN2 ), and the MBL-associated serine protease gene ( MASP2 ) of recipients and donors were determined. Recipients receiving a donor liver in the principal cohort with polymorphisms in all three components i.e., MBL2 (XA/O; O/O), FCN2 +6359T, and MASP2 +371A, had a cumulative risk of an infection of 75% as compared to 18% with wild-type donor livers ( P = 0.002), an observation confirmed in the second cohort ( P = 0.04). In addition, a genetic (mis)match between donor and recipient conferred a two-fold higher infection risk for each separate gene. Multivariate Cox analysis revealed a stepwise increase in infection risk with the lectin pathway gene profile of the donor (hazard ratio = 4.52; P = 8.1 × 10−6) and the donor-recipient (mis)match genotype (hazard ratio = 6.41; P = 1.9 × 10−7), independent from the other risk factors sex and antibiotic prophylaxis (hazard ratio > 1.7 and P < 0.02). Moreover, patients with a lectin pathway gene polymorphism and infection had a six-fold higher mortality ( P = 0.9 × 10−8), of which 80% was infection-related. Conclusion: Donor and recipient gene polymorphisms in the lectin complement pathway are major determinants of the risk of clinically significant bacterial infection and mortality after OLT.Keywords
This publication has 42 references indexed in Scilit:
- Donor Mannose‐Binding Lectin Deficiency Increases the Likelihood of Clinically Significant Infection after Liver TransplantationClinical Infectious Diseases, 2009
- Bacterial, mycobacterial, and protozoal infections after liver transplantation—Part ILiver Transplantation, 2005
- Disease-associated Mutations in Human Mannose-binding Lectin Compromise Oligomerization and Activity of the Final ProteinJournal of Biological Chemistry, 2004
- Ficolins and the lectin complement pathwayImmunological Reviews, 2001
- Acute Respiratory Tract Infections and Mannose-Binding Lectin Insufficiency During Early ChildhoodJAMA, 2001
- Cutting Edge: Complement-Activating Complex of Ficolin and Mannose-Binding Lectin-Associated Serine ProteaseThe Journal of Immunology, 2000
- Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital seriesBMJ, 1997
- Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiencyThe Lancet, 1995
- Mannose binding protein gene mutations associated with unusual and severe infections in adultsThe Lancet, 1995
- Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.Journal of Experimental Medicine, 1992